DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
20.80
+0.41 (2.01%)
At close: Apr 28, 2026, 4:00 PM EDT
20.80
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:04 PM EDT
DBV Technologies Revenue
In the year 2025, DBV Technologies had annual revenue of $5.64M with 35.77% growth. DBV Technologies had revenue of $645.00K in the quarter ending December 31, 2025, with 26.22% growth.
Revenue (ttm)
$5.64M
Revenue Growth
+35.77%
P/S Ratio
222.12
Revenue / Employee
$48,171
Employees
117
Market Cap
1.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.64M | 1.49M | 35.77% |
| Dec 31, 2024 | 4.15M | -11.58M | -73.61% |
| Dec 31, 2023 | 15.73M | 10.88M | 224.69% |
| Dec 31, 2022 | 4.84M | -864.00K | -15.14% |
| Dec 31, 2021 | 5.71M | -5.57M | -49.38% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharming Group | 376.13M |
| UroGen Pharma | 109.79M |
| AbCellera Biologics | 75.13M |
| Septerna | 45.95M |
| EyePoint | 31.37M |
| uniQure | 16.10M |
| Zenas BioPharma | 10.00M |
| Aktis Oncology | 6.50M |
DBVT News
- 26 days ago - DBV Technologies S.A.: Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 - Finanz Nachrichten
- 26 days ago - Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 - GlobeNewsWire
- 4 weeks ago - DBV Technologies S.A.: DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document - Finanz Nachrichten
- 4 weeks ago - DBV Technologies S.A.: DBV Technologies Reports Full Year 2025 Financial Results and Business Update - Finanz Nachrichten
- 4 weeks ago - DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document - GlobeNewsWire
- 4 weeks ago - DBV Technologies Reports Full Year 2025 Financial Results and Business Update - GlobeNewsWire
- 5 weeks ago - DBV Technologies S.A.: DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review - Finanz Nachrichten
- 5 weeks ago - DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review - GlobeNewsWire